Skip to main content

Sofinnova Investments, Inc.

Position in EWTX — Edgewise Therapeutics, Inc.

CIK 1631134 Menlo Park, CA

Position in EWTX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$15,476,901
+$3,302,214 QoQ
Shares Held
380,923
-1.4% QoQ
Ownership
0.351%
of shares outstanding
% of Portfolio
0.83%
of 13F equity value
Holder Rank
#43
of 225 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in EWTX Over Time

Shares Held

Position Value (USD)

Derivatives in EWTX

reported options exposure · as of Mar 31, 2025
CallValue
$0
CallShares
0
PutValue
$7,048,800
PutShares
320,400

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Sofinnova Investments, Inc. holds $1,182,454,857 across 43 Biotechnology names. EWTX ranks #23 (1.3% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in EWTX

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $15,476,901 380,923
2026-03-31 $12,174,687 386,498
2025-12-31 $10,864,478 437,819
2025-09-30 $8,438,292 520,240
2025-06-30 $9,398,205 716,873
2025-03-31 $7,528,796 342,218
2025-03-31 $7,048,800 320,400
2024-12-31 $10,754,039 402,773
2024-09-30 $10,269,431 384,767
2024-06-30 $8,567,194 475,691